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Purpose: Age-related macular degeneration (AMD) and glaucoma are the two most common 
blinding eye diseases in the U.S. and may be further disabling when concomitant. The purpose of 
this study is to estimate the past, present and future co-prevalence of AMD and glaucoma by 
national surveys and population projection data. 
Methods: We combined the age, race and ethnicity data from the latest 2005 to 2008 National 
Health and Nutrition Examination Survey (NHANES) and the 2002 and 2008 National Health 
Interview Survey (NHIS). Participants’ positive answers were defined as a “yes” when asked if 
they had ever been told by a doctor/health care professional that they had macular degeneration or 
glaucoma (or high pressure of the eye). The co-prevalence of AMD and glaucoma was 
determined by dividing the number of individuals who answered “yes” to both questions by the 
total number of respondents. Mean and age-stratified estimates were obtained for non-Hispanic 
Whites, Hispanics and non-Hispanic Blacks separately. The 2008 National Population Projection 
data was used to determine the number of affected individuals presently as well as in 2030 and 
2050.  
Results: Using previous NHANES and NHIS data, the mean co-prevalence of AMD and 
glaucoma varied among racial/ethnic groups: 0.5% in Whites; 0.3% in Hispanics; and 0.2% in 
Blacks. Co-prevalence increased with increasing age: for Whites, estimates ranged from 0% in 
those aged 40-49 years to 2.7% for 80 years and older; this trend was observed among the other 
groups but was more dramatic in Hispanics (0.1% to 2.9%) than Blacks (0% to 0.3%). Using 
National Population Projection data for 2015, the estimated current population is 535,270 (83% 
Whites; 10% Hispanics; 7% Blacks). The number of affected individuals will continue to grow 
but demonstrate changing demographics: in 2030 to 800,111 (80% Whites; 14% Hispanics; 7% 
Blacks); and in 2050 to 1,082,731 (71% Whites; 22% Hispanics; 6% Blacks). 
Conclusions: The mean co-prevalence of AMD and glaucoma is greatest among non-Hispanic 
Whites and individuals 70 years and older. More than half-a-million Americans, predominantly 
non-Hispanic Whites, suffer from concomitant eye diseases presently. Growing populations in the 
coming years will affect an increasing number of Hispanics. This new information suggests that 
future health care policy decisions would need to adapt to this growing, changing population. 
